Beneficial Modulation of Lipid Mediator Biosynthesis in Innate Immune Cells by Antirheumatic Tripterygium wilfordii Glycosides
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Beneficial Modulation of Lipid Mediator Biosynthesis in Innate Immune Cells by Antirheumatic Tripterygium wilfordii Glycosides
Authors
Keywords
-
Journal
Biomolecules
Volume 11, Issue 5, Pages 746
Publisher
MDPI AG
Online
2021-05-18
DOI
10.3390/biom11050746
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Anti-inflammatory celastrol promotes a switch from leukotriene biosynthesis to formation of specialized pro-resolving lipid mediators
- (2021) Simona Pace et al. PHARMACOLOGICAL RESEARCH
- Specialized pro-resolving mediator network: an update on production and actions
- (2020) Nan Chiang et al. Essays in Biochemistry
- Eicosanoids
- (2020) Philip C. Calder Essays in Biochemistry
- The Atlas of Inflammation Resolution (AIR)
- (2020) Charles N. Serhan et al. MOLECULAR ASPECTS OF MEDICINE
- Staphylococcus aureus-Derived α-Hemolysin Evokes Generation of Specialized Pro-resolving Mediators Promoting Inflammation Resolution
- (2020) Paul M. Jordan et al. Cell Reports
- Tripterygium Ingredients for Pathogenicity Cells in Rheumatoid Arthritis
- (2020) Yujun Tang et al. Frontiers in Pharmacology
- Tripterygium wilfordii : An inspiring resource for rheumatoid arthritis treatment
- (2020) Yanqiong Zhang et al. MEDICINAL RESEARCH REVIEWS
- The effectiveness and safety of Tripterygium wilfordii glycosides combined with disease‐modifying anti‐rheumatic drugs in the treatment of rheumatoid arthritis: A systematic review and meta‐analysis of 40 randomized controlled trials
- (2020) Wenhao Zheng et al. PHYTOTHERAPY RESEARCH
- Targeting biosynthetic networks of the proinflammatory and proresolving lipid metabolome
- (2019) Markus Werner et al. FASEB JOURNAL
- Novel benzoxanthene lignans that favorably modulate lipid mediator biosynthesis: A promising pharmacological strategy for anti-inflammatory therapy
- (2019) Jana Gerstmeier et al. BIOCHEMICAL PHARMACOLOGY
- A systematic review on the role of eicosanoid pathways in rheumatoid arthritis
- (2018) Malvina Hoxha Advances in Medical Sciences
- Resolvins in inflammation: emergence of the pro-resolving superfamily of mediators
- (2018) Charles N. Serhan et al. JOURNAL OF CLINICAL INVESTIGATION
- Human macrophages differentially produce specific resolvin or leukotriene signals that depend on bacterial pathogenicity
- (2018) Oliver Werz et al. Nature Communications
- A Mechanistic Overview of Triptolide and Celastrol, Natural Products from Tripterygium wilfordii Hook F
- (2018) Shao-Ru Chen et al. Frontiers in Pharmacology
- The Effectiveness and Safety of Tripterygium wilfordii Hook. F Extracts in Rheumatoid Arthritis: A Systematic Review and Meta-Analysis
- (2018) Ying-Yan Zhou et al. Frontiers in Pharmacology
- Diagnosis and Management of Rheumatoid Arthritis
- (2018) Daniel Aletaha et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Immune resolution mechanisms in inflammatory arthritis
- (2017) Mauro Perretti et al. Nature Reviews Rheumatology
- LTB 4 and BLT1 in inflammatory arthritis
- (2017) Yoshishige Miyabe et al. SEMINARS IN IMMUNOLOGY
- Resolvin D3 Is Dysregulated in Arthritis and Reduces Arthritic Inflammation
- (2016) Hildur H. Arnardottir et al. JOURNAL OF IMMUNOLOGY
- Specialised pro-resolving mediators of inflammation in inflammatory arthritis
- (2016) Anne E. Barden et al. PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS
- Perspective of microsomal prostaglandin E2 synthase-1 as drug target in inflammation-related disorders
- (2015) Andreas Koeberle et al. BIOCHEMICAL PHARMACOLOGY
- 5-Lipoxygenase, a key enzyme for leukotriene biosynthesis in health and disease
- (2015) Olof Rådmark et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS
- Comparison ofTripterygium wilfordiiHook F with methotrexate in the treatment of active rheumatoid arthritis (TRIFRA): a randomised, controlled clinical trial
- (2014) Qian-wen Lv et al. ANNALS OF THE RHEUMATIC DISEASES
- Elucidation of the molecular mechanism and the efficacyin vivoof a novel 1,4-benzoquinone that inhibits 5-lipoxygenase
- (2014) A M Schaible et al. BRITISH JOURNAL OF PHARMACOLOGY
- Pro-resolving lipid mediators are leads for resolution physiology
- (2014) Charles N. Serhan NATURE
- Comparison ofTripterygium wilfordiiHook F Versus Sulfasalazine in the Treatment of Rheumatoid Arthritis
- (2013) Raphaela Goldbach-Mansky ANNALS OF INTERNAL MEDICINE
- Specialized pro-resolving lipid mediators in the inflammatory response: An update
- (2010) Gerard Bannenberg et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS
- Rheumatoid arthritis
- (2010) David L Scott et al. LANCET
- Expression of 5-lipoxygenase and 15-lipoxygenase in rheumatoid arthritis synovium and effects of intraarticular glucocorticoids
- (2009) Karina Roxana Gheorghe et al. ARTHRITIS RESEARCH & THERAPY
- Licofelone Suppresses Prostaglandin E2 Formation by Interference with the Inducible Microsomal Prostaglandin E2 Synthase-1
- (2008) A. Koeberle et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Thromboxane A2: Physiology/pathophysiology, cellular signal transduction and pharmacology
- (2008) Norimichi Nakahata PHARMACOLOGY & THERAPEUTICS
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started